The objective: to evaluate the efficacy and safety of delamanid in a short-course treatment regimen for patients with MDR/pre-XDR pulmonary tuberculosis Arkhangelsk Region from 2019 2021. Subjects Methods. 32 (4 MDR TB 28 pre-XDR TB) started within combination chemotherapy new drugs, lasted 12 months. All received delamanid, bedaquiline, linezolid, clofazimine, then was compiled depending on cl...